Tier 3 — preclinical
β-Nicotinamide Mononucleotide Enhances Skin Barrier Function and Attenuates UV-B-Induced Photoaging in Mice
Antioxidants
2025
14(12):1424
Bibliography
- PubMed
- PMID 41462625
- PubMed Central
- PMC12729516
- Funding
- Supported by Korean Technology Innovation Program grants RS-2025-13642970 and RS-2025-09452988 from MOTIR/MOTIE.
- Competing interests
- Five authors (Seok-Seon Roh, Mu Hyun Jin, Sangki Park, Minji Park and Ho Song Cho) were employed by LG Household and Healthcare Ltd.; remaining authors reported no commercial or financial conflicts. Government funders were reported not to influence the study.
Study snapshot
| Design | Controlled 10-week animal study of oral NMN supplementation in UV-B-induced photoaging. |
|---|---|
| Model | SKH-1 hairless mice exposed to UV-B radiation. |
| Sample | Mouse experimental groups; no human participants. |
| Intervention | Oral β-NMN supplementation during a 10-week UV-B photoaging protocol. |
| Duration | 10 weeks |
| Endpoints | Wrinkle formation; Skin roughness; Hydration; Elasticity; Transepidermal water loss; Collagen density; Epidermal thickness; MAPK signaling; Inflammatory cytokines; MMP-1; Hyaluronan synthase; Antioxidant defense |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Citation network
Articles citing this research paper
Biohack Blueprint analyses that reference this study in their evidence base.
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified



